Haiying Sun

Jiangsu Key Laboratory Of Drug Design And Optimization
Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Discovery of Activators of Human Caseinolytic Protease P with a Benzolactam Scaffold.

Discovery of Activators of Human Caseinolytic Protease P with a Benzolactam Scaffold.

Journal: Journal of medicinal chemistry

Published: February 20, 2026

Discovery of SaClpP-Selective Imipridone Derivatives as Novel Antistaphylococcal Agents.

Discovery of SaClpP-Selective Imipridone Derivatives as Novel Antistaphylococcal Agents.

Journal: Journal of medicinal chemistry

Published: July 03, 2025

Design, Synthesis, and Biological Evaluation of Novel Activators of Human Caseinolytic Protease P with a Pyrazololactam Scaffold.

Design, Synthesis, and Biological Evaluation of Novel Activators of Human Caseinolytic Protease P with a Pyrazololactam Scaffold.

Journal: Journal of medicinal chemistry

Published: May 03, 2025

Discovery of Dehydrogenated Imipridone Derivatives as Activators of Human Caseinolytic Protease P.

Discovery of Dehydrogenated Imipridone Derivatives as Activators of Human Caseinolytic Protease P.

Journal: Journal of medicinal chemistry

Published: August 22, 2024

Development of Small Molecular Hyper-activators of Human Caseinolytic Peptidase P (hClpP) with a [1,8]-naphthyridinone Scaffold as Novel Anti-cancer Agents.

Development of Small Molecular Hyper-activators of Human Caseinolytic Peptidase P (hClpP) with a [1,8]-naphthyridinone Scaffold as Novel Anti-cancer Agents.

Journal: ChemMedChem

Published: August 15, 2024

Development of novel imipridone derivatives with potent anti-cancer activities as human caseinolytic peptidase P (hClpP) activators.

Development of novel imipridone derivatives with potent anti-cancer activities as human caseinolytic peptidase P (hClpP) activators.

Journal: Bioorganic chemistry

Published: May 14, 2024

Efficient and scalable synthesis of 3,4-dihydroisoquinolin-1(2H)-ones by benzylic oxidation of tetrahydroisoquinoline derivatives using cerium ammonium nitrate (CAN).

Efficient and scalable synthesis of 3,4-dihydroisoquinolin-1(2H)-ones by benzylic oxidation of tetrahydroisoquinoline derivatives using cerium ammonium nitrate (CAN).

Journal: Organic & biomolecular chemistry

Published: May 08, 2024

Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein-Protein Interactions between DOT1L and MLL-AF9/MLL-ENL.

Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein-Protein Interactions between DOT1L and MLL-AF9/MLL-ENL.

Journal: Journal of medicinal chemistry

Published: May 25, 2022

Progress in the development of domain selective inhibitors of the bromo and extra terminal domain family (BET) proteins.

Progress in the development of domain selective inhibitors of the bromo and extra terminal domain family (BET) proteins.

Journal: European journal of medicinal chemistry

Published: July 02, 2021

Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK).

Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK).

Journal: Journal of medicinal chemistry

Published: October 15, 2020

N-terminal modified cyclopeptidic mimetics of ApolloTBM as inhibitors of TRF2.

N-terminal modified cyclopeptidic mimetics of ApolloTBM as inhibitors of TRF2.

Journal: Bioorganic & medicinal chemistry letters

Published: March 16, 2020

Development and optimization of a cascade of screening assays for inhibitors of TRF2.

Development and optimization of a cascade of screening assays for inhibitors of TRF2.

Journal: Analytical biochemistry

Published: February 15, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026